These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26149392)

  • 41. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW; Chen C; Chokkalingam AP; Gao YT; Dightman DA; Nguyen HT; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Reichardt JK
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prostate cancer incidence in guadeloupe, a French Caribbean archipelago.
    Mallick S; Blanchet P; Multigner L
    Eur Urol; 2005 Jun; 47(6):769-72. PubMed ID: 15925071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of prostate-specific antigen testing on familial prostate cancer risk estimates.
    Bratt O; Garmo H; Adolfsson J; Bill-Axelson A; Holmberg L; Lambe M; Stattin P
    J Natl Cancer Inst; 2010 Sep; 102(17):1336-43. PubMed ID: 20724726
    [TBL] [Abstract][Full Text] [Related]  

  • 44. International trends in prostate-cancer mortality in the "PSA ERA".
    Oliver SE; May MT; Gunnell D
    Int J Cancer; 2001 Jun; 92(6):893-8. PubMed ID: 11351313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostate Cancer Working Group report.
    Namiki M; Akaza H; Lee SE; Song JM; Umbas R; Zhou L; Lee BC; Cheng C; Chung MK; Fukagai T; Hinotsu S; Horie S
    Jpn J Clin Oncol; 2010 Sep; 40 Suppl 1():i70-75. PubMed ID: 20870924
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median.
    Loeb S; Nadler RB; Roehl KA; Antenor JA; Catalona WJ
    J Urol; 2007 May; 177(5):1745-8. PubMed ID: 17437803
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gastric cancer in the Arab World: a systematic review.
    Aoude M; Mousallem M; Abdo M; Youssef B; Kourie HR; Al-Shamsi HO
    East Mediterr Health J; 2022 Jul; 28(7):521-531. PubMed ID: 35959668
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is prostate cancer incidence worldwide linked to artificial light at night exposures? Review of earlier findings and analysis of current trends.
    Rybnikova NA; Haim A; Portnov BA
    Arch Environ Occup Health; 2017 Mar; 72(2):111-122. PubMed ID: 27029744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cancer epidemiology in South-West Asia - past, present and future.
    Salim EI; Moore MA; Bener A; Habib OS; Seif-Eldin IA; Sobue T
    Asian Pac J Cancer Prev; 2010; 11 Suppl 2():33-48. PubMed ID: 20553067
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Similarities and disparities in cancer burden among Arab world females.
    Hussain LM; Benbrahim Z; Kunter GM; Elsayed Z; Gafer N; Hussain AM; Al-Mansouri L; Alizzi S; Jazieh AR
    Gulf J Oncolog; 2021 May; 1(36):36-41. PubMed ID: 35017134
    [TBL] [Abstract][Full Text] [Related]  

  • 51. With increasing trends of prostate cancer in the Saudi Arabia and Arab World: Should we start screening programs?
    Arafa MA; Rabah DM
    World J Clin Oncol; 2017 Dec; 8(6):447-449. PubMed ID: 29291169
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostate cancer in the Arab world: Bibliometric review and research priority recommendations.
    Ali AH; Awada H; Nassereldine H; Zeineddine M; Sater ZA; El-Hajj A; Mukherji D
    Arab J Urol; 2022; 20(2):81-87. PubMed ID: 35530565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Limited improvement in prostate cancer mortality-to-incidence ratios in countries with high health care expenditures.
    Wang SC; Chan L; Hsieh TY; Wang CH; Chen SL; Sung WW
    Aging (Albany NY); 2020 Nov; 12(21):21308-21315. PubMed ID: 33216731
    [TBL] [Abstract][Full Text] [Related]  

  • 54. International trends in prostatic cancer.
    Zaridze DG; Boyle P; Smans M
    Int J Cancer; 1984 Feb; 33(2):223-30. PubMed ID: 6693200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estrogen: one of the risk factors in milk for prostate cancer.
    Qin LQ; Wang PY; Kaneko T; Hoshi K; Sato A
    Med Hypotheses; 2004; 62(1):133-42. PubMed ID: 14729019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiology of prostate cancer.
    Dijkman GA; Debruyne FM
    Eur Urol; 1996; 30(3):281-95. PubMed ID: 8931959
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epidemiology of prostatic cancer in East Asia.
    Sasagawa I; Nakada T
    Arch Androl; 2001; 47(3):195-201. PubMed ID: 11695843
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comprehensive review of epilepsy in the Arab world.
    Bhalla D; Lotfalinezhad E; Timalsina U; Kapoor S; Kumar KS; Abdelrahman A; Giagante B; Tripathi M; Srivastava K; Irmansyah I
    Seizure; 2016 Jan; 34():54-9. PubMed ID: 26724591
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidemiology and prevention of prostate cancer in Vietnam.
    Van Dong H; Lee AH; Nga NH; Quang N; Le Chuyen V; Binns CW
    Asian Pac J Cancer Prev; 2014; 15(22):9747-51. PubMed ID: 25520098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostate cancer control--aims of the UICC Asia Regional Office Consortium.
    Cheng C; Akaza H; Chen KK; Moore MA; Naito S; Song JM; Umbas R; Xia S;
    Asian Pac J Cancer Prev; 2006; 7(3):350-68. PubMed ID: 17059324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.